Alzheimer's Association criticises Nymox:
This article was originally published in Clinica
The US Alzheimer's Association has recommended against using Nymox' AD7C test. The association says there is no published data on the test's ability to rule out Alzheimer's disease and describes Nymox' marketing as aggressive and objectionable. The test detects neural thread proteins, which the Alzheimer's Association says is also found in people with brain tumours and stoke victims. Nymox promotes the test directly on the World Wide Web.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.